Lower Research

 
News Articles for Lower Research top ^
2014/6/14
Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering Than Liraglutide When Both Were Added to Insulin Glargine Canada NewsWire PARIS , June 14, 2014 /CNW/ - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia ® (lixisenatide) met the primary endpoint in an 8-week head-to-head pharmacodynamic study versus liraglutide, showing a significantly more pronounced post-prandial (after-meal) glucose (blood sugar) lowering effect after a test-meal than liraglutide when both were added to optimally titrated Lantus ® (insulin glargine). Lowering of post-prandial glucose was measured as change from baseline in incremental area under the glucose curve for 4 hours after a standardized solid breakfast, at week 8.
Sign-up for Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering Than Liraglutide When Both Were Added to Insulin Glargine investment picks
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that on July 11, dosing commenced of the first patients enrolled in the Company’s Phase 3 registration clinical trials of Rhopressa TM , a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
Sign-up for Aerie Pharmaceuticals Initiates Phase 3 Registration Trials of RhopressaTM, Novel Triple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma investment picks
2014/8/26
By Alex MacDonald LONDON--Chilean copper producer Antofagasta PLC (ANTO.LN) said Tuesday that earnings fell in the first half of the year due to lower copper output and prices but reaffirmed its full-year guidance.
Sign-up for Antofagasta Net Profit Drops on Lower Copper Output, Price investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Urban Outfitters Inc. shares declined in the extended session Monday as lower margins trumped better-than-expected quarterly earnings and sales results.
Sign-up for Urban Outfitters shares decline on lower margins investment picks
2014/8/17
MELBOURNE, Australia--National Australia Bank Ltd.'s (NAB.AU) earnings rose in its fiscal third quarter, as expenses fell and the lender recorded lower charges for soured loans.
Sign-up for National Australia Bank Reports Lower Bad Debt investment picks
PennEast Pipeline Will Reduce Energy Costs for Homes and Businesses and Enhance Reliability WYOMISSING, Pa.
Sign-up for PennEast Pipeline Company, LLC, Announces Project To Supply Lower Cost Marcellus Natural Gas To Mid-Atlantic Region investment picks
2014/9/8
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market opened lower on Monday as recent peaks on the main benchmark and a lack of economic data contributed to cautiousness among global stock investors.
Sign-up for MARKET SNAPSHOT: U.S. Stocks Open Lower; Deals In Focus investment picks
2014/9/8
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch NEW YORK (MarketWatch) -- The U.S. stock market opened lower on Monday as recent peaks on the main benchmark and a lack of economic data contributed to cautiousness among global stock investors.
Sign-up for UPDATE: U.S. stocks open lower; deals in focus investment picks
2014/9/3
By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch)-- Falling Apple Inc. shares dragged the S&P 500 lower in Wednesday trading.
Sign-up for UPDATE: U.S. stocks end mostly lower, hurt by Apple investment picks
2014/6/17
By Daniel Inman Asian markets were mostly down on Tuesday, with Shanghai leading the region lower, while Australia was weighed by further falls in mining stocks.
Sign-up for UPDATE: Asia stocks mostly lower, but Japan moves higher investment picks
2014/6/14
PARIS , June 14, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that Lyxumia ® (lixisenatide) met the primary endpoint in an 8-week head-to-head pharmacodynamic study versus liraglutide, showing a significantly more pronounced post-prandial (after-meal) glucose (blood sugar) lowering effect after a test-meal than liraglutide when both were added to optimally titrated Lantus ® (insulin glargine). Lowering of post-prandial glucose was measured as change from baseline in incremental area under the glucose curve for 4 hours after a standardized solid breakfast, at week 8.
Sign-up for Sanofi's Lyxumia® (lixisenatide) Showed More Pronounced After-Test-Meal Blood Sugar Lowering than Liraglutide when Both were Added to Insulin Glargine investment picks
2014/6/26
NEW YORK , June 26, 2014 /PRNewswire/ -- BNY Mellon, a global leader in investment management and investment services, announced today that it will relocate its world headquarters to Brookfield Place, a premier complex in Lower Manhattan's Battery Park City.
Sign-up for BNY Mellon Announces Move of World Headquarters to Brookfield Place in Lower Manhattan investment picks
2014/7/9
By Sara Sjolin, MarketWatch LONDON (MarketWatch)--U.K. stocks posted some of the biggest losses in Europe on Wednesday as insurance firms headed sharply lower, leading the European benchmark index to a small drop for a fourth straight day.
Sign-up for UPDATE: U.K.'s FTSE 100 yanked lower by insurers investment picks
2014/7/9
By Robert Wall FRANKFURT--Deutsche Lufthansa AG said Wednesday it would cut capacity growth, seek lower-costs on long-haul flights, and operate some of its European service through its Eurowings affiliate to improve profitability after earlier restructuring measures failed to deliver the promised profit improvement.
Sign-up for Lufthansa to cut capacity, offset lower costs on long haul investment picks
2014/7/25
By Joseph Adinolfi, MarketWatch NEW YORK (MarketWatch) -- Five analysts lowered share-price targets for Amazon Friday, though most maintained a long-term bullish outlook after the release of the company's second-quarter earnings report, which was mostly in-line with Street expectations.
Sign-up for Analysts lower Amazon share-price targets investment picks
2014/8/22
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K.'s FTSE 100 ended a choppy session slightly lower on Friday, with mining firms continuing their push lower, while Vodafone Group PLC climbed after acquisition news.
Sign-up for LONDON MARKETS: FTSE 100 Ends Choppy Day Lower As Miners Weigh investment picks
2014/8/22
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K.'s FTSE 100 ended a choppy session slightly lower on Friday, with mining firms continuing their push lower, while Vodafone Group PLC climbed after acquisition news.
Sign-up for UPDATE: FTSE 100 ends choppy day lower as miners weigh investment picks
2014/8/20
Asian stocks were mixed Thursday, with China lower after a weak report on Chinese manufacturing activity.
Sign-up for Asian Shares Mixed, China Lower After Weak PMI Data investment picks
2014/8/20
By Chao Deng Asian stocks were mixed Thursday, with China lower after a weak report on Chinese manufacturing activity.
Sign-up for Asian Shares Mixed; China Lower on Data investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Urban Outfitters Inc. shares declined in the extended session Monday as lower margins trumped better-than-expected quarterly earnings and sales results.
Sign-up for UPDATE: Urban Outfitters shares decline on lower margins investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Lower Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Lower Operating  |  Next: Lower Sales